发布求助
文献互助 智能选刊 最新文献

Lung Cancer Management最新文献

筛选
英文 中文
Cost of lung cancer diagnosis: cost differences between national health system and private sector 肺癌诊断成本：国家卫生系统与私营部门的成本差异
IF 0.9
Lung Cancer Management Pub Date : 2024-07-15 DOI: 10.1080/17581966.2024.2370227
P. Zarogoulidis, Vasilis Papadopoulos, E. Perdikouri, A. Vagionas, D. Matthaios, Rena Oikonomidou, Wolfgang Hohemforst-Schmidt, Haidong Huang, C. Bai, Oikonomou Panagoula, C. Nikolaou, Charalampos Charalampidis, C. Kosmidis, K. Sapalidis, Savvas Petanidis
{"title":"Cost of lung cancer diagnosis: cost differences between national health system and private sector","authors":"P. Zarogoulidis, Vasilis Papadopoulos, E. Perdikouri, A. Vagionas, D. Matthaios, Rena Oikonomidou, Wolfgang Hohemforst-Schmidt, Haidong Huang, C. Bai, Oikonomou Panagoula, C. Nikolaou, Charalampos Charalampidis, C. Kosmidis, K. Sapalidis, Savvas Petanidis","doi":"10.1080/17581966.2024.2370227","DOIUrl":"https://doi.org/10.1080/17581966.2024.2370227","url":null,"abstract":"","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141649331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic 向单次分次外周肺立体定向体放射治疗迈进：全球 COVID-19 大流行期间和之后的患者护理
IF 0.9
Lung Cancer Management Pub Date : 2024-07-03 DOI: 10.1080/17581966.2024.2367369
S. Alfaifi, Vibhay Pareek, Julian Kim, S. Rathod, William Hunter, A. Leylek, Naseer Ahmed, Sankar Venkataraman, Niranjan Venugopal, Amitava D Chowdhury, Arbind Dubey, S. Kakumanu, B. Bashir
{"title":"Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic","authors":"S. Alfaifi, Vibhay Pareek, Julian Kim, S. Rathod, William Hunter, A. Leylek, Naseer Ahmed, Sankar Venkataraman, Niranjan Venugopal, Amitava D Chowdhury, Arbind Dubey, S. Kakumanu, B. Bashir","doi":"10.1080/17581966.2024.2367369","DOIUrl":"https://doi.org/10.1080/17581966.2024.2367369","url":null,"abstract":"","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141680608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis 患有无细胞淋巴瘤激酶重排的肺癌患者在确诊时失去了与劳动力市场的联系
IF 2.8
Lung Cancer Management Pub Date : 2024-03-13 DOI: 10.2217/lmt-2023-0013
Jon Lykkegaard Andersen, Jakob Sidenius Johansen, E. Urbanska, P. Meldgaard, Peter Hjorth-Hansen, Charlotte Kristiansen, Miroslaw Stelmach, Eric Santoni-Rugiu, M. P. Ulhoi, Betina Højgaard, Morten Sall Jensen, A. B. Dydensborg, C. Dünweber, K. H. Hansen
{"title":"Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis","authors":"Jon Lykkegaard Andersen, Jakob Sidenius Johansen, E. Urbanska, P. Meldgaard, Peter Hjorth-Hansen, Charlotte Kristiansen, Miroslaw Stelmach, Eric Santoni-Rugiu, M. P. Ulhoi, Betina Højgaard, Morten Sall Jensen, A. B. Dydensborg, C. Dünweber, K. H. Hansen","doi":"10.2217/lmt-2023-0013","DOIUrl":"https://doi.org/10.2217/lmt-2023-0013","url":null,"abstract":"Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion: ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140247668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory parameters in NSCLC with driver mutation 有驱动基因突变的 NSCLC 的炎症参数
IF 2.8
Lung Cancer Management Pub Date : 2024-02-28 DOI: 10.2217/lmt-2023-0014
M. E. Buyukbayram, Zekeriya Hannarici, A. Yılmaz, A. Turhan, Alperen Akansel Caglar, Pınar Coban Esdur, M. Bilici, S. B. Tekin
{"title":"Inflammatory parameters in NSCLC with driver mutation","authors":"M. E. Buyukbayram, Zekeriya Hannarici, A. Yılmaz, A. Turhan, Alperen Akansel Caglar, Pınar Coban Esdur, M. Bilici, S. B. Tekin","doi":"10.2217/lmt-2023-0014","DOIUrl":"https://doi.org/10.2217/lmt-2023-0014","url":null,"abstract":"Aim: The tumor microenvironment of NSCLC with driver mutations, such as EGFR, ALK and ROS, is less inflammatory. Materials & methods: This retrospective study included 38 patients with NSCLC driver mutations. The relationship between clinical and inflammatory markers concerning progression-free survival and overall survival was analyzed based on Kaplan-Meier curves. Results: The mean age of the patients was 59.8 ± 11.9. Progression-free survival and overall survival were significantly longer in patients under 65 years of age and with low neutrophil–lymphocyte ratio, low systemic immune-inflammation index and high lymphocyte count (p < 0.05). Conclusion: Unlike tumor biology, peripheral inflammatory parameters, such as neutrophil–lymphocyte ratio, systemic immune-inflammation index and lymphocyte count may be associated with survival in NSCLC patients with driver mutations.","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140418031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic significance of systemic immune inflammatory index in NSCLC: a meta-analysis NSCLC全身免疫炎症指数的预后意义：一项荟萃分析
IF 2.8
Lung Cancer Management Pub Date : 2024-02-28 DOI: 10.2217/lmt-2023-0010
Wen-Hua Chen, Jing-Jing Shao, Ying Yang, Yun Meng, Sheng Huang, Rong-Fang Xu, Ji-Bin Liu, Jian-Guo Chen, Qin Wang, Hai-Zhen Chen
{"title":"Prognostic significance of systemic immune inflammatory index in NSCLC: a meta-analysis","authors":"Wen-Hua Chen, Jing-Jing Shao, Ying Yang, Yun Meng, Sheng Huang, Rong-Fang Xu, Ji-Bin Liu, Jian-Guo Chen, Qin Wang, Hai-Zhen Chen","doi":"10.2217/lmt-2023-0010","DOIUrl":"https://doi.org/10.2217/lmt-2023-0010","url":null,"abstract":"Aim: The aim of this meta-analysis was to investigate the relationship between the baseline systemic immune inflammatory index (SII) and prognosis in patients with NSCLC. Materials & methods: The relation between pretreatment SII and overall survival, disease-free survival, cancer-specific survival, progression-free survival and recurrence-free survival in NSCLC patients was analyzed combined with hazard ratio and 95% CI. Results: The results showed that high SII was significantly correlated with overall survival and progression-free survival of NSCLC patients, but not with disease-free survival, cancer-specific survival and recurrence-free survival. Conclusion: The study suggests that a higher SII has association with worse prognosis in NSCLC patients. PROSPERO registration number: CRD42022336270 .","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140418310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies. 交感神经系统功能增强会影响肺癌患者的预后：临床研究范围综述。
IF 2.8
Lung Cancer Management Pub Date : 2024-01-16 eCollection Date: 2023-12-01 DOI: 10.2217/lmt-2023-0006
Fabrício T Garramona, Telma F Cunha, Janaína S Vieira, Gabriela Borges, Gabriela Santos, Gilberto de Castro, Carlos Ugrinowitsch, Patrícia C Brum
{"title":"Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies.","authors":"Fabrício T Garramona, Telma F Cunha, Janaína S Vieira, Gabriela Borges, Gabriela Santos, Gilberto de Castro, Carlos Ugrinowitsch, Patrícia C Brum","doi":"10.2217/lmt-2023-0006","DOIUrl":"10.2217/lmt-2023-0006","url":null,"abstract":"<p><strong>Aim: </strong>To summarize current knowledge, gaps, quality of the evidence and show main results related to the role of the autonomic nervous system in lung cancer.</p><p><strong>Methods: </strong>Studies were identified through electronic databases (PubMed, Scopus, Embase and Cochrane Library) in October 2023, and a descriptive analysis was performed. Twenty-four studies were included, and most were observational.</p><p><strong>Results: </strong>Our data indicated an increased expression of β-2-adrenergic receptors in lung cancer, which was associated with poor prognosis. However, the use of β-blockers as an add-on to standard treatment promoted enhanced overall survival, recurrence-free survival and reduced metastasis occurrence.</p><p><strong>Conclusion: </strong>Although the results herein seem promising, future research using high-quality prospective clinical trials is required to draw directions to guide clinical interventions.</p>","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794895/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139492429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value of combined detection of plasma cfDNA concentration and integrity in NSCLC 联合检测 NSCLC 血浆 cfDNA 浓度和完整性的诊断价值
IF 2.8
Lung Cancer Management Pub Date : 2024-01-11 DOI: 10.2217/lmt-2023-0009
Sai Ren, Chunli Yu, Qing Huang
{"title":"Diagnostic value of combined detection of plasma cfDNA concentration and integrity in NSCLC","authors":"Sai Ren, Chunli Yu, Qing Huang","doi":"10.2217/lmt-2023-0009","DOIUrl":"https://doi.org/10.2217/lmt-2023-0009","url":null,"abstract":"Aim: To evaluate the value of combined detection of plasma cfDNA concentration and integrity in the early diagnosis of NSCLC. Methods: Real-time fluorescence quantitative PCR was used to determine the concentration and integrity of plasma cfDNA in 71 NSCLC patients and 53 healthy people. Results: Combined detection of plasma cfDNA concentration and integrity had higher diagnostic power in differentiating NSCLC patients with stage I/II from healthy people than detection of plasma cfDNA concentration alone or integrity alone. The AUC, sensitivity and specificity of the combined detection of plasma cfDNA concentration and integrity were 0.781, 0.62 and 0.85. Conclusion: Combined detection of plasma cfDNA concentration and integrity could improve the diagnostic value in NSCLC detection.","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Achieving long-term survival in extensive-stage SCLC: a case report and mini literature review 实现广泛期SCLC的长期生存：病例报告和小型文献综述
IF 2.8
Lung Cancer Management Pub Date : 2024-01-11 DOI: 10.2217/lmt-2023-0012
Yayun Mao, Meiping Huang, Jiafu Liu
{"title":"Achieving long-term survival in extensive-stage SCLC: a case report and mini literature review","authors":"Yayun Mao, Meiping Huang, Jiafu Liu","doi":"10.2217/lmt-2023-0012","DOIUrl":"https://doi.org/10.2217/lmt-2023-0012","url":null,"abstract":"Managing extensive-stage SCLC (ES-SCLC) has long been challenging for clinicians and oncologists due to its aggressive nature and poor prognosis. We report a case of a 41-year-old female with ES-SCLC who survived for six years, defying the disease's typically poor prognosis. Through a heavy treatment strategy involving chemotherapy, targeted therapy, and immunotherapy, the patient experienced robust responses and avoided distant metastasis, including brain involvement. The long-term survival case in SCLC highlights the need for further research into personalized strategies and prognostic biomarkers. This case holds significant value for both clinicians and researchers as it challenges the conventional strategies for ES-SCLC and sets the stage for future evidence-based studies aimed at extending survival in SCLC.","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139626683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral synchronous multiple lung cancer: an emerging problem 双侧同步多发性肺癌：一个新出现的问题
IF 2.8
Lung Cancer Management Pub Date : 2023-12-19 DOI: 10.2217/lmt-2023-0008
Huajian Liu, Liam Polley
{"title":"Bilateral synchronous multiple lung cancer: an emerging problem","authors":"Huajian Liu, Liam Polley","doi":"10.2217/lmt-2023-0008","DOIUrl":"https://doi.org/10.2217/lmt-2023-0008","url":null,"abstract":"Aim: Multiple primary lung cancers are becoming increasingly recognised and pose diagnostic and staging uncertainties with challenging management options and prognostication. Case report: We describe a case of synchronous multiple primary lung cancer occurring bilaterally, and the steps in reaching the diagnosis, initial surgical management, the intensive follow-up this underwent, and how its subsequent recurrence led to treatment with radiation therapy in light of the patient's declining fitness. Discussion: This case highlighted that cytological recurrence could occur prior to radiological recurrence, especially for endobronchial tumors, and intensive follow-up both radiologically and endoscopically with multidisciplinary input is crucial in the management of these challenging cases where evidence-based guidelines are limited.","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138959664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective study of ensartinib-treated ALK-positive locally advanced or metastatic NSCLC patients in China 恩沙替尼治疗中国alk阳性局部晚期或转移性NSCLC患者的回顾性研究
Lung Cancer Management Pub Date : 2023-11-07 DOI: 10.2217/lmt-2023-0005
Xiaobin Yuan, Yang Wang, Min Yang, Pengxiang Wu, Hui Chen, Yu Yun, Zhilin Shen, Dong Ji, Yongbin Ma, Lieming Ding
{"title":"A retrospective study of ensartinib-treated <i>ALK</i>-positive locally advanced or metastatic NSCLC patients in China","authors":"Xiaobin Yuan, Yang Wang, Min Yang, Pengxiang Wu, Hui Chen, Yu Yun, Zhilin Shen, Dong Ji, Yongbin Ma, Lieming Ding","doi":"10.2217/lmt-2023-0005","DOIUrl":"https://doi.org/10.2217/lmt-2023-0005","url":null,"abstract":"Aim: This retrospective study aimed to assess the efficacy and safety of ensartinib in Chinese patients with ALK-positive advanced NSCLC in real-world clinical practice. Methods: Clinical data from ALK-positive NSCLC patients treated with ensartinib in China were collected and analyzed. Efficacy end points included objective response rate and progression-free survival. Safety profiles were also evaluated. Results: A total of 682 patients were included in this study. The study demonstrated promising efficacy with an objective response rate of 54.0%, and the median progression-free survival was not estimable. Ensartinib exhibited a manageable safety profile with treatment-related adverse events (TRAEs) consistent with prior clinical trials. The most common TRAE was rash (21.1%) and no TRAE led to death. Conclusion: Ensartinib is active and well tolerated for ALK-positive NSCLC patients in real-world clinical settings.","PeriodicalId":43551,"journal":{"name":"Lung Cancer Management","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135476086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信